Product Code: GVR-4-68039-945-6
Acute Wound Care Market Growth & Trends:
The global acute wound care market size is expected to reach USD 11.96 billion in 2030 and is projected to grow at a CAGR of 4.3% from 2025 to 2030. A rise in burn incidence cases, an increase in the global geriatric population, and rising cases of traumatic accidents are expected to be the key driving factors for the market.
The global rise in various burn cases is contributing to the growth of the market. For instance, according to ImpactLaw, out of total chemical burn cases, 22,000 cases are due to exposure to acid. Similarly, 55,500 burn cases can be accredited to exposure to alkaline solutions. Moreover, as per the NCBI, each day, an estimated 30,000 people suffer from burn injuries, whereas, it is predicted that annually, approximately 11 million people suffer due to burn incidents. Acute wound care products such as advanced wound dressing are used to treat burn marks. Thus, rising burn incidences are expected to drive the market.
Furthermore, the number of traumatic incidences such as abrasion, lacerations, road accidents, and assaults is growing. For instance, according to stats by the NCBI, abrasions are the most common form of injury in children accounting for 70.7% of all injuries. Similarly, as per the Bureau of Labor Statistics, U.S. Department of Labor, 2.7 million non-fatal injuries were reported by private industry labor in 2020. Moreover, according to Brady United, every year, around 117,345 people are shot down leading to acute wounds. As there has been a rise in acute wounds due to the above-mentioned factors, the market is anticipated to grow over the forecast period.
The COVID-19 pandemic resulted in a minor decrease in the market size. However, with the availability of vaccines and ease of lockdown, the market is expected to grow during the post-pandemic period. This can be attributed to various strategic initiatives by major market players, along with improvements in the home healthcare system. For instance, in January 2022, ConvaTec Group PLC entered into a definitive agreement with Triad Life Sciences Inc. According to this agreement, ConvaTec will acquire Triad Life Sciences Inc. in order to strengthen its advanced wound care business.
Acute Wound Care Market Report Highlights:
- On the basis of product, advanced wound dressing captured the largest revenue share of over 34.9% in 2024. This can be attributed to a rise in the number of accident cases globally
- Based on application, the surgical and traumatic wounds segment dominated the market with a share of over 80.1% in 2024 and is projected to witness the fastest growth over the forecast period
- On the basis of end-use, the hospitals segment dominated the market in 2024. Home healthcare is estimated to register the fastest growth rate over the forecast period
- North America dominated the market in 2024. Asia Pacific is anticipated to register the fastest growth rate over the forecast period owing to a rise in traumatic accidents and the growing geriatric population in this region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Acute Wound Care Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Acute Wound Care Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social Landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental Landscape
- 3.4.2.5. Legal Landscape
Chapter 4. Acute Wound Care Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Acute Wound Care Market: Product Movement Analysis, 2024 & 2030 (USD Million)
- 4.3. Advanced Wound Dressing
- 4.3.1. Advanced Wound Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.1.1. Foam Dressings
- 4.3.1.1.1. Foam Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.1.2. Hydrocolloid Dressings
- 4.3.1.2.1. Hydrocolloid Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.1.3. Film Dressings
- 4.3.1.3.1. Film Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.1.4. Alginate Dressings
- 4.3.1.4.1. Alginate Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.1.5. Hydrogel Dressings
- 4.3.1.5.1. Hydrogel Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.1.6. Collagen Dressings
- 4.3.1.6.1. Collagen Dressings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Surgical Wound Care
- 4.4.1. Surgical Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.1.1. Sutures & Staples
- 4.4.1.1.1. Sutures & Staples Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.1.2. Tissue Adhesives and Sealants
- 4.4.1.2.1. Tissue Adhesives and Sealants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.1.3. Anti-infective Dressing
- 4.4.1.3.1. Anti-infective Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Traditional Wound Care
- 4.5.1. Traditional Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.1. Medical Tapes
- 4.5.1.1.1. Medical Tapes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.2. Cleansing Agents
- 4.5.1.2.1. Cleansing Agents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.3. Others
- 4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Wound Therapy Devices
- 4.6.1. Wound Therapy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.1.1. Negative Pressure Wound Therapy
- 4.6.1.1.1. Negative Pressure Wound Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.1.2. Oxygen and Hyperbaric Oxygen Equipment
- 4.6.1.2.1. Oxygen and Hyperbaric Oxygen Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.1.3. Electric Stimulation Devices
- 4.6.1.3.1. Electric Stimulation Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.1.4. Pressure Relief Devices
- 4.6.1.4.1. Pressure Relief Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.1.5. Others
- 4.6.1.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Acute Wound Care Market: End Use Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Acute Wound Care Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
- 5.3. Hospitals
- 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Specialty Clinics
- 5.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Home Healthcare
- 5.5.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Acute Wound Care Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Acute Wound Care Market: Application Movement Analysis, 2023 & 2030 (USD Million)
- 6.3. Surgical & Traumatic Wound
- 6.3.1. Surgical & Traumatic Wound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Burns
- 6.4.1. Burns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Acute Wound Care Market: Regional Estimates & Trend Analysis
- 7.1. Acute Wound Care Market Share, By Region, 2024 & 2030, USD Million
- 7.2. North America
- 7.2.1. North America Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1 Key Country Dynamics
- 7.2.2.2 Regulatory Framework/Reimbursement Structure
- 7.2.2.3 Competitive Scenario
- 7.2.2.4. U.S. Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
- 7.2.3.1 Key Country Dynamics
- 7.2.3.2 Regulatory Framework/Reimbursement Structure
- 7.2.3.3 Competitive Scenario
- 7.2.3.4. Canada Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1 Key Country Dynamics
- 7.2.4.2 Regulatory Framework/Reimbursement Structure
- 7.2.4.3 Competitive Scenario
- 7.2.4.4. Mexico Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Acute Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
- 7.3.2.1 Key Country Dynamics
- 7.3.2.2 Regulatory Framework/Reimbursement Structure
- 7.3.2.3 Competitive Scenario
- 7.3.2.4. UK Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1 Key Country Dynamics
- 7.3.3.2 Regulatory Framework/Reimbursement Structure
- 7.3.3.3 Competitive Scenario
- 7.3.3.4. Germany Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
- 7.3.4.1 Key Country Dynamics
- 7.3.4.2 Regulatory Framework/Reimbursement Structure
- 7.3.4.3 Competitive Scenario
- 7.3.4.4. France Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
- 7.3.5.1 Key Country Dynamics
- 7.3.5.2 Regulatory Framework/Reimbursement Structure
- 7.3.5.3 Competitive Scenario
- 7.3.5.4. Italy Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
- 7.3.6.1 Key Country Dynamics
- 7.3.6.2 Regulatory Framework/Reimbursement Structure
- 7.3.6.3 Competitive Scenario
- 7.3.6.4. Spain Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1 Key Country Dynamics
- 7.3.7.2 Regulatory Framework/Reimbursement Structure
- 7.3.7.3 Competitive Scenario
- 7.3.7.4. Denmark Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1 Key Country Dynamics
- 7.3.8.2 Regulatory Framework/Reimbursement Structure
- 7.3.8.3 Competitive Scenario
- 7.3.8.4. Sweden Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
- 7.3.9.1 Key Country Dynamics
- 7.3.9.2 Regulatory Framework/Reimbursement Structure
- 7.3.9.3 Competitive Scenario
- 7.3.9.4. Norway Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Acute Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Japan
- 7.4.2.1 Key Country Dynamics
- 7.4.2.2 Regulatory Framework/Reimbursement Structure
- 7.4.2.3 Competitive Scenario
- 7.4.2.4. Japan Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. China
- 7.4.3.1 Key Country Dynamics
- 7.4.3.2 Regulatory Framework/Reimbursement Structure
- 7.4.3.3 Competitive Scenario
- 7.4.3.4. China Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
- 7.4.4.1 Key Country Dynamics
- 7.4.4.2 Regulatory Framework/Reimbursement Structure
- 7.4.4.3 Competitive Scenario
- 7.4.4.4. India Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Australia
- 7.4.5.1 Key Country Dynamics
- 7.4.5.2 Regulatory Framework/Reimbursement Structure
- 7.4.5.3 Competitive Scenario
- 7.4.5.4. Australia Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. South Korea
- 7.4.6.1 Key Country Dynamics
- 7.4.6.2 Regulatory Framework/Reimbursement Structure
- 7.4.6.3 Competitive Scenario
- 7.4.6.4. South Korea Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1 Key Country Dynamics
- 7.4.7.2 Regulatory Framework/Reimbursement Structure
- 7.4.7.3 Competitive Scenario
- 7.4.7.4. Canada Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1 Key Country Dynamics
- 7.5.2.2 Regulatory Framework/Reimbursement Structure
- 7.5.2.3 Competitive Scenario
- 7.5.2.4. Brazil Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
- 7.5.3.1 Key Country Dynamics
- 7.5.3.2 Regulatory Framework/Reimbursement Structure
- 7.5.3.3 Competitive Scenario
- 7.5.3.4. Argentina Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Acute Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1 Key Country Dynamics
- 7.6.2.2 Regulatory Framework/Reimbursement Structure
- 7.6.2.3 Competitive Scenario
- 7.6.2.4. South Africa Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1 Key Country Dynamics
- 7.6.3.2 Regulatory Framework/Reimbursement Structure
- 7.6.3.3 Competitive Scenario
- 7.6.3.4. Saudi Arabia Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. UAE
- 7.6.4.1 Key Country Dynamics
- 7.6.4.2 Regulatory Framework/Reimbursement Structure
- 7.6.4.3 Competitive Scenario
- 7.6.4.4. UAE Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1 Key Country Dynamics
- 7.6.5.2 Regulatory Framework/Reimbursement Structure
- 7.6.5.3 Competitive Scenario
- 7.6.5.4. Kuwait Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Heat Map Analysis
- 8.4. Company Profiles
- 8.4.1. 3M
- 8.4.1.1. Participant's Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Coloplast Corp
- 8.4.2.1. Participant's Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Smith + Nephew
- 8.4.3.1. Participant's Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Medtronic
- 8.4.4.1. Participant's Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. ConvaTec Group PLC
- 8.4.5.1. Participant's Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Integra LifeSciences
- 8.4.6.1. Participant's Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Ethicon (Johnson & Johnson)
- 8.4.7.1. Participant's Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Baxter
- 8.4.8.1. Participant's Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Molnlycke Health Care AB
- 8.4.9.1. Participant's Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Recent Developments/ Strategic Initiatives